ÂÜÀòÂÒÂ×

Dr. Gilles Tapolsky has over thirty years in the areas of preclinical and clinical drug development. Gilles has worked for both large international and emerging biotech companies. His experience includes drug discovery, R&D and translational research, preclinical studies, pharmaceutical development, CMC and clinical development. He has submitted multiple INDs, developed the BEMA® technology and contributed to the clinical development of several novel antineoplastic agents. Gilles was previously CSO at Advanced Cancer Therapeutics where he directed the preclinical and clinical development of multiple novel compounds and holds more than 60 patents. He received his Ph.D. in Chemistry from the University of Paris and an M.B.A. from Rice University.